Endocrinology CME

Two activities at present:

Obstructive Sleep Apnea and the Cardiometabolic Syndrome: Clinical Perspectives and Interrelationships “will teach you to recognize the sometimes subtle, nonspecific symptoms and clinical presentation of obstructive sleep apnea, and why you should refer both patients with suspected OSA and patients with cardiometabolic syndrome to a sleep specialist for evaluation and intervention.”

Handling the Hand-off: Transitioning from Pediatric to Adult Diabetes Care “was developed from presentations made at the live symposium titled Handling the Hand-off: Transitioning from Pediatric to Adult Diabetes Care that took place on August 6, 2010, in San Antonio, TX, as part of the AADE’s Annual Meeting.

Target Audience: Physicians specializing in Endocrinology

CME activities of special interest to endocrinologists. Medscape contains a variety of educational formats:

CONFERENCE COVERAGE – Reports of advances presented at major medical conferences; typically includes several tracks with news stories, expert interviews, and in-depth topic overviews.

CLINICAL UPDATE – Comprehensive original review article on scientific advances in a clinical topic.

FAST TRACK CLINICAL UPDATE – Narrowly focused original review article on scientific advances in a clinical topic.

CME-LIVE – Real-time online events with streaming video, synchronized visuals, and interactive questions and answers; archived for 1 year.

CLINICAL BRIEFS – Daily reports of major current medical research articles; 0.25 credits each

JOURNAL CME – Articles selected from a wide selection of peer-reviewed journals.
SPECIAL REPORT CME – Topic-based monthly email newsletter distributed to Medscape’s professional member database by specialty.

INTERACTIVE PATIENT CASES – Original CME activity presented to the physician in an interactive, clinical case-based format. (See especially eMedicine CME Case Presentations.)
CME CIRCLE – Multimedia content certified by other accredited professional education providers, typically from live symposia or monographs, and then posted on Medscape and archived for one year.

Target Audience: Physicians specializing in Endocrinology

New perspectives in diabetes offers knowledge, competency, and practice improvements in the diagnosis, management, and treatment of patients with type 2 diabetes mellitus. The following topics are discussed:
• The Role of the Kidney in Glucose Homeostasis
• Prevention of CVD Events in Diabetes
• The Role of SGLT2 Inhibition in T2DM
• Improving Patient-Provider Communication Techniques
• The Value of Managing the ABCs: A1C, blood pressure, and Cholesterol
• When Should We Use SGLT2 Inhibitors?
• Emerging T2DM Therapies Targeting the Kidney
• Interactive Case : Patient with inadequate control of A1C levels currently on metformin
• Interactive Case : Type 2 Diabetes Mellitus with CV Risk
• Summaries of recently published articles with expert perspective on how results can be applied in clinical practice

Target Audience: Physicians focusing on Endocrinology

Gaucher disease (GD) is characterized by a deficiency of the lysosomal enzyme glucocerebrosidase, resulting in the accumulation of sphingolipids throughout the body but most manifesting prominently in the bones. GD is subcategorized based on clinical features: type 1 GD is the non-neuronopathic form and affects mainly the inner organs, while types 2 and 3 are the acute and sub-acute neuropathic forms, whose pathology manifests predominantly within central nervous system. GD impacts about 1 in 75,000 births, making it one of the most common lysosomal storage diseases. One of the first of GD’s complications is the chronic anemia and a persistent bleeding risk. Another is the hepatosplenomegaly, which may be a part of the initial clinical presentation, as may the anatomical abnormalities of bone deformities and stunted growth.

By the end of the session the participant will be able to:

• Describe the pathogenesis, clinical presentations, complications, and epidemiology of Gaucher disease including updated recently presented material
• Describe principles and problems regarding screening for and diagnosing Gaucher disease that can applied to patient cases
• Describe emerging therapies for Gaucher disease based on research recently presented
• Design and implement appropriate therapeutic plans for treatment of Gaucher disease based on research recently presented

Target Audience:

The following healthcare professionals: pediatricians, neurologists, endocrinologists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists; and any other healthcare professionals with an interest in or who may clinically encounter patients with Gaucher disease.